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Introduction
Primary cartilaginous tumors of the larynx are rare neo-
plasms. Chondrosarcomas constitute less than 1% of all
laryngeal tumors. They are more commonly reported in
Asian populations and have a 6:1 male/female ratio. Their
clinical manifestation is often as painless unilateral cervi-
cal lymphadenopathy or as subcutaneous masses in the
head and neck region.
Photodynamic therapy has previously been shown to
reduce the bulk of tumours and vascular malformations.
Case report
A 74-year-old Caucasian male presented with asympto-
matic, slowly enlarging swelling of the anterior neck.
Radiological and histopathological investigation revealed
a low grade chondrosarcoma of the hyoid bone and
extending to involve most of the base of tongue and ante-
rior laryngeal wall.
The patient was offered surgical excision of the sarcoma
which would require sacrificing the larynx, base of tongue
and the hyoid, but rejected. It was felt that other medical
management (i.e. chemo-radiotherapy) was not the opti-
mal choice.
Interstitial PDT was performed using a baseline MRI scan
as a guide. Clinical and radiological assessments at fol-
low-up showed a promising reduction in lesional size.
Conclusion
Conventional management of chondrosarcoma includes
conservative, intra-lesional steroids, chemotherapeutic
drugs, radiotherapy and surgical excision. Unfortunately
none of which are curative as the lesion inevitably recurs.
The authors commend PDT as a repeatable treatment
option in management of these lesions.
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